{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:15:16Z","timestamp":1787318116920,"version":"build-2736575974"},"reference-count":143,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T00:00:00Z","timestamp":1633910400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T00:00:00Z","timestamp":1633910400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Diabetes Endocrinol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Gestational diabetes mellitus (GDM) is glucose intolerance first recognised during pregnancy. Both modalities and thresholds of the GDM diagnostic test, the Oral Glucose Tolerance Test (OGTT), have varied widely over time and among countries. Additionally, OGTT limitations include inconsistency, poor patient tolerability, and questionable diagnostic reliability. Many biological parameters have been reported to be modified by GDM and could potentially be used as diagnostic indicators. This study aimed\u00a0to 1) systematically explore biomarkers reported in the literature as differentiating GDM from healthy pregnancies\u00a02) screen those indicators assessed against OGTT to propose OGTT alternatives.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main body<\/jats:title>\n                    <jats:p>A systematic review of GDM\u00a0diagnostic indicators was performed according to PRISMA guidelines (PROSPERO registration\u00a0CRD42020145499).\u00a0Inclusion criteria were\u00a0full-text, comprehensible English-language articles published January 2009-January 2021, where a biomarker (from blood, ultrasound, amniotic fluid, placenta) was compared between GDM and normal glucose tolerance (NGT) women from the second trimester onward to immediately postpartum. GDM diagnostic method had to be clearly specified, and the number of patients per study higher than 30 in total or 15 per group. Results were synthesised by biomarkers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 13,133 studies identified in initial screening, 174 studies (135,801 participants) were included. One hundred and twenty-nine studies described blood analytes, one amniotic fluid analytes, 27 ultrasound features, 17 post-natal features. Among the biomarkers evaluated in exploratory studies, Adiponectin, AFABP, Betatrophin, CRP, Cystatin-C, Delta-Neutrophil Index, GGT, TNF-A were those demonstrating statistically and clinically significant differences in substantial cohorts of patients (&gt;\u2009500). Regarding biomarkers assessed versus OGTT (i.e. potential OGTT alternatives) most promising were Leptin\u2009&gt;\u200948.5 ng\/ml, Ficolin3\/adiponectin ratio\u2009\u2265\u20091.06, Chemerin\/FABP\u2009&gt;\u20090.71, and Ultrasound Gestational Diabetes Score\u2009&gt;\u20094. These all demonstrated sensitivity and specificity\u2009&gt;\u200980% in adequate sample sizes (&gt;\u2009\/\u2009=\u2009100).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Numerous biomarkers may differentiate GDM from normoglycaemic pregnancy.\u00a0Given the limitations of the OGTT and the lack of a gold standard for GDM diagnosis, advanced phase studies are needed to triangulate the most promising biomarkers. Further studies are also recommended to assess the sensitivity and specificity of promising biomarkers not yet assessed against OGTT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>PROSPERO registration number CRD42020145499.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40842-021-00126-7","type":"journal-article","created":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T05:06:16Z","timestamp":1633928776000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["The diagnostic indicators of gestational diabetes mellitus from second trimester to birth: a systematic review"],"prefix":"10.1186","volume":"7","author":[{"given":"Daria","family":"Di Filippo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiyasha","family":"Wanniarachchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer J.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aoife","family":"Mc Sweeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alys","family":"Havard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7389-0513","authenticated-orcid":false,"given":"Alec","family":"Welsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,11]]},"reference":[{"issue":"3","key":"126_CR1","first-page":"129","volume":"1","author":"AB Gilmartin","year":"2008","unstructured":"Gilmartin AB, Ural SH, Repke JT. Gestational diabetes mellitus. Rev Obstet Gynecol. 2008;1(3):129\u201334.","journal-title":"Rev Obstet Gynecol"},{"issue":"3","key":"126_CR2","doi-asserted-by":"publisher","first-page":"676","DOI":"10.2337\/dc09-1848","volume":"33","author":"International Association of, D","year":"2010","unstructured":"International Association of, D, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33(3):676\u201382.","journal-title":"Diabetes Care"},{"issue":"Suppl","key":"126_CR3","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.2337\/dc15-S005","volume":"38","author":"A American Diabetes","year":"2015","unstructured":"American Diabetes A. (2) Classification and diagnosis of diabetes. Diabetes Care. 2015;38(Suppl):S8\u201316.","journal-title":"Diabetes Care"},{"key":"126_CR4","doi-asserted-by":"publisher","first-page":"696","DOI":"10.3389\/fendo.2018.00696","volume":"9","author":"EA Huhn","year":"2018","unstructured":"Huhn EA, et al. Controversies in screening and diagnostic criteria for gestational diabetes in early and late pregnancy. Front Endocrinol. 2018;9:696.","journal-title":"Front Endocrinol"},{"issue":"6","key":"126_CR5","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/j.1479-828X.2005.00481.x","volume":"45","author":"NW Cheung","year":"2005","unstructured":"Cheung NW, Oats JJ, McIntyre HD. Australian carbohydrate intolerance study in pregnant women: implications for the management of gestational diabetes. Aust N Z J Obstet Gynaecol. 2005;45(6):484\u20135.","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"2","key":"126_CR6","doi-asserted-by":"publisher","first-page":"453","DOI":"10.2337\/db08-1112","volume":"58","author":"Group H.S.C.R","year":"2009","unstructured":"Group H.S.C.R. Hyperglycemia and adverse pregnancy outcome (HAPO) study: associations with neonatal anthropometrics. Diabetes. 2009;58(2):453\u20139.","journal-title":"Diabetes"},{"key":"126_CR7","doi-asserted-by":"publisher","first-page":"306","DOI":"10.3389\/fendo.2017.00306","volume":"8","author":"M Castillo-Castrejon","year":"2017","unstructured":"Castillo-Castrejon M, Powell TL. Placental nutrient transport in gestational diabetic pregnancies. Front Endocrinol. 2017;8:306.","journal-title":"Front Endocrinol"},{"issue":"1","key":"126_CR8","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/ijgo.12427","volume":"141","author":"C Marais","year":"2018","unstructured":"Marais C, et al. Randomized cross-over trial comparing the diagnosis of gestational diabetes by oral glucose tolerance test and a designed breakfast glucose profile. Int J Gynaecol Obstet. 2018;141(1):85\u201390.","journal-title":"Int J Gynaecol Obstet"},{"key":"126_CR9","doi-asserted-by":"crossref","unstructured":"Sert UY, Ozgu-Erdinc AS. Gestational diabetes mellitus screening and diagnosis. Adv Exp Med Biol.\u00a02020;1307:231\u201355.","DOI":"10.1007\/5584_2020_512"},{"issue":"9","key":"126_CR10","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.clinbiochem.2017.01.012","volume":"50","author":"E Mansell","year":"2017","unstructured":"Mansell E, Lunt H, Docherty P. Laboratory diagnosis of gestational diabetes: an in silico investigation into the effects of pre-analytical processing on the diagnostic sensitivity and specificity of the oral glucose tolerance test. Clin Biochem. 2017;50(9):506\u201312.","journal-title":"Clin Biochem"},{"issue":"7","key":"126_CR11","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.2337\/dc20-0304","volume":"43","author":"JM Potter","year":"2020","unstructured":"Potter JM, et al. Strict preanalytical oral glucose tolerance test blood sample handling is essential for diagnosing gestational diabetes mellitus. Diabetes Care. 2020;43(7):1438\u201341.","journal-title":"Diabetes Care"},{"key":"126_CR12","unstructured":"Programme, C.A.S. CASP checklists. 2020 [cited 30 Nov 2020]."},{"issue":"1","key":"126_CR13","doi-asserted-by":"publisher","first-page":"14","DOI":"10.2214\/ajr.184.1.01840014","volume":"184","author":"S Weinstein","year":"2005","unstructured":"Weinstein S, Obuchowski NA, Lieber ML. Clinical evaluation of diagnostic tests. AJR Am J Roentgenol. 2005;184(1):14\u20139.","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"126_CR14","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ejogrb.2010.05.035","volume":"152","author":"T Tantanasis","year":"2010","unstructured":"Tantanasis T, et al. Sonographic assessment of fetal subcutaneous fat tissue thickness as an indicator of gestational diabetes. Eur J Obstet Gynecol Reprod Biol. 2010;152(2):157\u201362.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"3","key":"126_CR15","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.diabres.2014.06.001","volume":"105","author":"J Trujillo","year":"2014","unstructured":"Trujillo J, et al. Fasting plasma glucose to avoid a full OGTT in the diagnosis of gestational diabetes. Diabetes Res Clin Pract. 2014;105(3):322\u20136.","journal-title":"Diabetes Res Clin Pract"},{"issue":"7","key":"126_CR16","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/0002-9378(82)90349-0","volume":"144","author":"MW Carpenter","year":"1982","unstructured":"Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol. 1982;144(7):768\u201373.","journal-title":"Am J Obstet Gynecol"},{"key":"126_CR17","unstructured":"WHO. Hyperglycaemia in pregnancy. In Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy. WHO, Editor. 2013, WHO: https:\/\/www.who.int\/diabetes\/publications\/Hyperglycaemia_In_Pregnancy\/en\/."},{"key":"126_CR18","doi-asserted-by":"crossref","unstructured":"Group N.-N.D.D. Classification and diagnosis of diabetes mellitus andother categories of glucose intolerance. National Diabetes Data Group.Diabetes. 1979;28(12):1039\u201357.","DOI":"10.2337\/diab.28.12.1039"},{"issue":"7","key":"126_CR19","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1111\/dme.12978","volume":"33","author":"JP Zhao","year":"2016","unstructured":"Zhao JP, et al. Longitudinal circulating concentrations of long-chain polyunsaturated fatty acids in the third trimester of pregnancy in gestational diabetes. Diabet Med. 2016;33(7):939\u201346.","journal-title":"Diabet Med"},{"issue":"9","key":"126_CR20","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1080\/14767058.2016.1199671","volume":"30","author":"SS Fatima","year":"2017","unstructured":"Fatima SS, et al. Elevated levels of chemerin, leptin, and interleukin-18 in gestational diabetes mellitus. J Matern Fetal Neonatal Med. 2017;30(9):1023\u20138.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"5","key":"126_CR21","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1111\/jdi.12484","volume":"7","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, et al. Changes in serum adipocyte fatty acid-binding protein in women with gestational diabetes mellitus and normal pregnant women during mid- and late pregnancy. J Diabetes Investig. 2016;7(5):797\u2013804.","journal-title":"J Diabetes Investig"},{"issue":"5","key":"126_CR22","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1530\/EC-18-0093","volume":"7","author":"H Rueangdetnarong","year":"2018","unstructured":"Rueangdetnarong H, et al. Comparisons of the oxidative stress biomarkers levels in gestational diabetes mellitus (GDM) and non-GDM among Thai population: cohort study. Endocr Connect. 2018;7(5):681\u20137.","journal-title":"Endocr Connect"},{"key":"126_CR23","doi-asserted-by":"publisher","first-page":"49","DOI":"10.7897\/2230-8407.10019","volume":"10","author":"A Abbas","year":"2019","unstructured":"Abbas A, et al. Association of serum preptin levels with insulin resistance in Iraqi women with gestational diabetes mellitus. Int Res J Pharm. 2019;10:49\u201355.","journal-title":"Int Res J Pharm"},{"issue":"11","key":"126_CR24","doi-asserted-by":"publisher","first-page":"837","DOI":"10.3109\/09513590.2012.683069","volume":"28","author":"SG Ma","year":"2012","unstructured":"Ma SG, et al. Evaluation of serum ischemia-modified albumin levels in pregnant women with and without gestational diabetes mellitus. Gynecol Endocrinol. 2012;28(11):837\u201340.","journal-title":"Gynecol Endocrinol"},{"issue":"3","key":"126_CR25","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1093\/ajcn\/nqy116","volume":"108","author":"P Li","year":"2018","unstructured":"Li P, et al. Plasma concentration of trimethylamine-N-oxide and risk of gestational diabetes mellitus. Am J Clin Nutr. 2018;108(3):603\u201310.","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"126_CR26","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1016\/j.dsx.2019.06.006","volume":"13","author":"S Alyas","year":"2019","unstructured":"Alyas S, et al. Early pregnancy biochemical markers of placentation for screening of gestational diabetes mellitus (GDM). Diabetes Metab Syndr. 2019;13(4):2353\u20136.","journal-title":"Diabetes Metab Syndr"},{"issue":"17","key":"126_CR27","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1080\/14767058.2018.1449201","volume":"32","author":"S Li","year":"2019","unstructured":"Li S, Yang H. Relationship between advanced glycation end products and gestational diabetes mellitus. J Matern Fetal Neonatal Med. 2019;32(17):2783\u20139.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"126_CR28","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.clinbiochem.2019.12.013","volume":"77","author":"J Zhang","year":"2020","unstructured":"Zhang J, et al. Characteristics of bone turnover markers in women with gestational diabetes mellitus. Clin Biochem. 2020;77:36\u201340.","journal-title":"Clin Biochem"},{"issue":"4","key":"126_CR29","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1507\/endocrj.EJ17-0508","volume":"65","author":"XS Yuan","year":"2018","unstructured":"Yuan XS, et al. Increased secreted frizzled-related protein 4 and ficolin-3 levels in gestational diabetes mellitus women. Endocr J. 2018;65(4):499\u2013508.","journal-title":"Endocr J"},{"key":"126_CR30","doi-asserted-by":"publisher","first-page":"3865454","DOI":"10.1155\/2016\/3865454","volume":"2016","author":"H Li","year":"2016","unstructured":"Li H, et al. Plasma markers of oxidative stress in patients with gestational diabetes mellitus in the second and third trimester. Obstet Gynecol Int. 2016;2016:3865454.","journal-title":"Obstet Gynecol Int"},{"issue":"13","key":"126_CR31","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1111\/1471-0528.13857","volume":"123","author":"J Ryser Ruetschi","year":"2016","unstructured":"Ryser Ruetschi J, et al. Fasting glycaemia to simplify screening for gestational diabetes. BJOG. 2016;123(13):2219\u201322.","journal-title":"BJOG"},{"key":"126_CR32","doi-asserted-by":"crossref","unstructured":"D\u2019Emden M, et al. Development of a fasting blood glucose-based strategy to diagnose women with gestational diabetes mellitus at increased risk of adverse outcomes in a COVID-19 environment. PLoS One. 2020;15(12):e0243192.","DOI":"10.1371\/journal.pone.0243192"},{"issue":"7","key":"126_CR33","doi-asserted-by":"publisher","first-page":"981","DOI":"10.2337\/dc16-2598","volume":"40","author":"P Ghosh","year":"2017","unstructured":"Ghosh P, et al. Plasma glycated CD59, a novel biomarker for detection of pregnancy-induced glucose intolerance. Diabetes Care. 2017;40(7):981\u20134.","journal-title":"Diabetes Care"},{"issue":"1","key":"126_CR34","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.diabres.2012.02.018","volume":"98","author":"R Rajput","year":"2012","unstructured":"Rajput R, et al. Utility of HbA1c for diagnosis of gestational diabetes mellitus. Diabetes Res Clin Pract. 2012;98(1):104\u20137.","journal-title":"Diabetes Res Clin Pract"},{"key":"126_CR35","doi-asserted-by":"crossref","unstructured":"Kwon SS, et al. HbA1c for diagnosis and prognosis of gestational diabetes mellitus. Diabetes Res Clin Pract. 2015;110(1):38\u201343.","DOI":"10.1016\/j.diabres.2015.07.014"},{"key":"126_CR36","doi-asserted-by":"crossref","unstructured":"Renz PB, et al. HbA1c Test as a Tool in the Diagnosis of Gestational Diabetes Mellitus. PLoS One. 2015;10(8): e0135989.","DOI":"10.1371\/journal.pone.0135989"},{"issue":"20","key":"126_CR37","doi-asserted-by":"publisher","first-page":"3497","DOI":"10.1080\/14767058.2019.1576169","volume":"33","author":"P Siricharoenthai","year":"2020","unstructured":"Siricharoenthai P, Phupong V. Diagnostic accuracy of HbA1c in detecting gestational diabetes mellitus. J Matern Fetal Neonatal Med. 2020;33(20):3497\u2013500.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"10","key":"126_CR38","first-page":"1731","volume":"70","author":"SH Khan","year":"2020","unstructured":"Khan SH, et al. Role of HbA1c in diagnosis of gestational diabetes mellitus. J Pak Med Assoc. 2020;70(10):1731\u20136.","journal-title":"J Pak Med Assoc"},{"issue":"10","key":"126_CR39","doi-asserted-by":"publisher","first-page":"e23435","DOI":"10.1002\/jcla.23435","volume":"34","author":"DA Rayis","year":"2020","unstructured":"Rayis DA, et al. Reliability of glycosylated hemoglobin in the diagnosis of gestational diabetes mellitus. J Clin Lab Anal. 2020;34(10):e23435.","journal-title":"J Clin Lab Anal"},{"issue":"16","key":"126_CR40","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.21037\/atm-20-5464","volume":"8","author":"Y Lai","year":"2020","unstructured":"Lai Y, et al. The diagnostic accuracy of HbA1c in detecting gestational diabetes mellitus among Chinese pregnant individuals. Ann Transl Med. 2020;8(16):1014.","journal-title":"Ann Transl Med"},{"key":"126_CR41","doi-asserted-by":"publisher","first-page":"48","DOI":"10.4274\/tjem.3482","volume":"20","author":"A \u00c7eltik","year":"2016","unstructured":"\u00c7eltik A. Mean platelet volume in women with gestational diabetes. Turk J Endocrinol Metabol. 2016;20:48\u201353.","journal-title":"Turk J Endocrinol Metabol"},{"key":"126_CR42","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jprot.2014.03.025","volume":"103","author":"D Dudzik","year":"2014","unstructured":"Dudzik D, et al. Metabolic fingerprint of gestational diabetes mellitus. J Proteomics. 2014;103:57\u201371.","journal-title":"J Proteomics"},{"issue":"11","key":"126_CR43","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s11306-018-1445-6","volume":"14","author":"X Chen","year":"2018","unstructured":"Chen X, et al. Metabolomic biomarkers and novel dietary factors associated with gestational diabetes in China. Metabolomics. 2018;14(11):149.","journal-title":"Metabolomics"},{"issue":"5","key":"126_CR44","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s00592-014-0626-7","volume":"51","author":"JV De Seymour","year":"2014","unstructured":"De Seymour JV, et al. Early pregnancy metabolite profiling discovers a potential biomarker for the subsequent development of gestational diabetes mellitus. Acta Diabetol. 2014;51(5):887\u201390.","journal-title":"Acta Diabetol"},{"issue":"7","key":"126_CR45","first-page":"1045","volume":"63","author":"S Zheng","year":"2017","unstructured":"Zheng S, et al. Metabolic profiling of plasma in gestational diabetes mellitus using liquid chromatography and Q-TOF mass spectrometry. Clin Lab. 2017;63(7):1045\u201355.","journal-title":"Clin Lab"},{"issue":"11","key":"126_CR46","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1507\/endocrj.K10E-231","volume":"57","author":"Y Saisho","year":"2010","unstructured":"Saisho Y, et al. Beta cell dysfunction and its clinical significance in gestational diabetes. Endocr J. 2010;57(11):973\u201380.","journal-title":"Endocr J"},{"issue":"1","key":"126_CR47","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.dsx.2013.10.016","volume":"8","author":"G Yousefzadeh","year":"2014","unstructured":"Yousefzadeh G, et al. Plasma cystatin-C and risk of developing gestational diabetes mellitus. Diabetes Metab Syndr. 2014;8(1):33\u20135.","journal-title":"Diabetes Metab Syndr"},{"key":"126_CR48","first-page":"OC14","volume":"91","author":"H Liu","year":"2015","unstructured":"Liu H, et al. Surrogate markers of the kidney and liver in the assessment of gestational diabetes mellitus and fetal outcome. J Clin Diagn Res. 2015;91:OC14-7.","journal-title":"J Clin Diagn Res"},{"key":"126_CR49","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3329\/bmj.v40i3.18678","volume":"40","author":"MR Sarker","year":"2014","unstructured":"Sarker MR, et al. Role of maternal iron status in the pathogenesis of gestational diabetes mellitus. Bangladesh Med J. 2014;40:55\u201360.","journal-title":"Bangladesh Med J"},{"key":"126_CR50","doi-asserted-by":"crossref","unstructured":"Gomathi KG et al. Plasma homocysteine and other biochemical parameters in gestational diabetes mellitus. 2011.","DOI":"10.5742\/MEJFM.2011.98080"},{"issue":"1","key":"126_CR51","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/1758-5996-6-120","volume":"6","author":"G Nar","year":"2014","unstructured":"Nar G, et al. The relationship between epicardial fat thickness and gestational diabetes mellitus. Diabetol Metab Syndr. 2014;6(1):120.","journal-title":"Diabetol Metab Syndr"},{"issue":"2","key":"126_CR52","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/jdi.12688","volume":"9","author":"XS Yuan","year":"2018","unstructured":"Yuan XS, et al. Ficolin-3\/adiponectin ratio for the prediction of gestational diabetes mellitus in pregnant women. J Diabetes Investig. 2018;9(2):403\u201310.","journal-title":"J Diabetes Investig"},{"issue":"4","key":"126_CR53","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1515\/jpm-2012-0227","volume":"41","author":"E Celik","year":"2013","unstructured":"Celik E, et al. Maternal and fetal adropin levels in gestational diabetes mellitus. J Perinat Med. 2013;41(4):375\u201380.","journal-title":"J Perinat Med"},{"issue":"1","key":"126_CR54","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3390\/ijms20010159","volume":"20","author":"R Mierzynski","year":"2019","unstructured":"Mierzynski R, et al. Nesfatin-1 and vaspin as potential novel biomarkers for the prediction and early diagnosis of gestational diabetes mellitus. Int J Mol Sci. 2019;20(1):159.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"126_CR55","doi-asserted-by":"publisher","first-page":"e92175","DOI":"10.1371\/journal.pone.0092175","volume":"9","author":"S Naf","year":"2014","unstructured":"Naf S, et al. Serum activin A and follistatin levels in gestational diabetes and the association of the activin A-follistatin system with anthropometric parameters in offspring. PLoS One. 2014;9(4):e92175.","journal-title":"PLoS One"},{"issue":"9","key":"126_CR56","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.2337\/dc11-0715","volume":"34","author":"H Ortega-Senovilla","year":"2011","unstructured":"Ortega-Senovilla H, et al. Gestational diabetes mellitus causes changes in the concentrations of adipocyte fatty acid-binding protein and other adipocytokines in cord blood. Diabetes Care. 2011;34(9):2061\u20136.","journal-title":"Diabetes Care"},{"issue":"1","key":"126_CR57","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1530\/EJE-08-0540","volume":"160","author":"S Kralisch","year":"2009","unstructured":"Kralisch S, et al. Serum levels of adipocyte fatty acid binding protein are increased in gestational diabetes mellitus. Eur J Endocrinol. 2009;160(1):33\u20138.","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"126_CR58","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1080\/09513590.2017.1306849","volume":"33","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, et al. Serum levels of nesfatin-1 are increased in gestational diabetes mellitus. Gynecol Endocrinol. 2017;33(8):621\u20134.","journal-title":"Gynecol Endocrinol"},{"issue":"6 Pt 1","key":"126_CR59","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.diabet.2010.06.006","volume":"36","author":"YX Su","year":"2010","unstructured":"Su YX, et al. Increased serum retinol-binding protein-4 levels in pregnant women with and without gestational diabetes mellitus. Diabetes Metab. 2010;36(6 Pt 1):470\u20135.","journal-title":"Diabetes Metab"},{"issue":"4","key":"126_CR60","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1111\/jog.13586","volume":"44","author":"M Shang","year":"2018","unstructured":"Shang M, Dong X, Hou L. Correlation of adipokines and markers of oxidative stress in women with gestational diabetes mellitus and their newborns. J Obstet Gynaecol Res. 2018;44(4):637\u201346.","journal-title":"J Obstet Gynaecol Res"},{"issue":"6","key":"126_CR61","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1177\/1933719117698576","volume":"25","author":"F Bugatto","year":"2018","unstructured":"Bugatto F, et al. The influence of lipid and proinflammatory status on maternal uterine blood flow in women with late onset gestational diabetes. Reprod Sci. 2018;25(6):837\u201343.","journal-title":"Reprod Sci"},{"issue":"3","key":"126_CR62","first-page":"158","volume":"10","author":"OB Sengul","year":"2009","unstructured":"Sengul OB, et al. Investigation of the correlation between 100 gram oral glucose tolerance test results and maternal leptin levels during pregnancy. J Turk Ger Gynecol Assoc. 2009;10(3):158\u201361.","journal-title":"J Turk Ger Gynecol Assoc"},{"issue":"2","key":"126_CR63","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1177\/0300060518808683","volume":"47","author":"R Pan","year":"2019","unstructured":"Pan R, et al. Betatrophin for diagnosis and prognosis of mothers with gestational diabetes mellitus. J Int Med Res. 2019;47(2):710\u20137.","journal-title":"J Int Med Res"},{"issue":"1","key":"126_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1530\/EJE-14-0815","volume":"173","author":"T Ebert","year":"2015","unstructured":"Ebert T, et al. Betatrophin levels are increased in women with gestational diabetes mellitus compared to healthy pregnant controls. Eur J Endocrinol. 2015;173(1):1\u20137.","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"126_CR65","doi-asserted-by":"publisher","first-page":"652","DOI":"10.3109\/09513590.2015.1056142","volume":"31","author":"O Erol","year":"2015","unstructured":"Erol O, et al. Evaluation of circulating betatrophin levels in gestational diabetes mellitus. Gynecol Endocrinol. 2015;31(8):652\u20136.","journal-title":"Gynecol Endocrinol"},{"key":"126_CR66","doi-asserted-by":"crossref","unstructured":"Amirian A et al. Predictive power of unconjugated estriol in diagnosis of gestational diabetes: a cohort study. Iran Red Crescent Med J.\u00a02019;21(11):e96471.","DOI":"10.5812\/ircmj.96471"},{"key":"126_CR67","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.eatbeh.2015.06.003","volume":"19","author":"Z Zhang","year":"2015","unstructured":"Zhang Z, et al. Association between circulating levels of galanin and pre-pregnancy body mass index in patients with gestational diabetes mellitus. Eat Behav. 2015;19:57\u201360.","journal-title":"Eat Behav"},{"issue":"1","key":"126_CR68","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12905-017-0373-3","volume":"17","author":"MA Tawfeek","year":"2017","unstructured":"Tawfeek MA, et al. Sex hormone binding globulin as a valuable biochemical marker in predicting gestational diabetes mellitus. BMC Womens Health. 2017;17(1):18.","journal-title":"BMC Womens Health"},{"issue":"4","key":"126_CR69","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1055\/s-0035-1565172","volume":"124","author":"T Ebert","year":"2016","unstructured":"Ebert T, et al. Serum levels of copeptin are decreased in gestational diabetes mellitus. Exp Clin Endocrinol Diabetes. 2016;124(4):257\u201360.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"126_CR70","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.peptides.2014.01.024","volume":"54","author":"Z Zhang","year":"2014","unstructured":"Zhang Z, et al. Endogenous galanin as a novel biomarker to predict gestational diabetes mellitus. Peptides. 2014;54:186\u20139.","journal-title":"Peptides"},{"issue":"3","key":"126_CR71","doi-asserted-by":"publisher","first-page":"236","DOI":"10.3109\/09513590.2013.871519","volume":"30","author":"S Nergiz","year":"2014","unstructured":"Nergiz S, et al. Circulating galanin and IL-6 concentrations in gestational diabetes mellitus. Gynecol Endocrinol. 2014;30(3):236\u201340.","journal-title":"Gynecol Endocrinol"},{"issue":"5","key":"126_CR72","doi-asserted-by":"publisher","first-page":"321","DOI":"10.5603\/DK.2020.0038","volume":"9","author":"A Khosrowbeygi","year":"2020","unstructured":"Khosrowbeygi A, Ahmadvand H. Maternal circulating status of vitamin D, adiponectin and lipid ratios in gestational diabetes mellitus. Clin Diabetol. 2020;9(5):321\u20137.","journal-title":"Clin Diabetol"},{"issue":"35","key":"126_CR73","doi-asserted-by":"publisher","first-page":"e21654","DOI":"10.1097\/MD.0000000000021654","volume":"99","author":"L Yaqiong","year":"2020","unstructured":"Yaqiong L, et al. Study on the levels of 25(OH)D, inflammation markers and glucose and fat metabolism indexes in pregnant women of Han nationality in Jiangsu province with gestational diabetes mellitus. Medicine. 2020;99(35):e21654.","journal-title":"Medicine"},{"issue":"3","key":"126_CR74","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.jdiacomp.2007.11.006","volume":"23","author":"M Afkhami-Ardekani","year":"2009","unstructured":"Afkhami-Ardekani M, Rashidi M. Iron status in women with and without gestational diabetes mellitus. J Diabetes Complications. 2009;23(3):194\u20138.","journal-title":"J Diabetes Complications"},{"key":"126_CR75","unstructured":"Ertv EY et al. Serum lipid profile and inflammatory status in women with gestational diabetes mellitus. 2016."},{"key":"126_CR76","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s13410-017-0571-4","volume":"38","author":"F Alam","year":"2018","unstructured":"Alam F, Shahbaz H, Khuwaja S, et al. Implication of soluble transferrin receptor and ferritin ratio in gestational diabetes. Int J Diabetes Dev Ctries. 2018;38:42\u20136.","journal-title":"Int J Diabetes Dev Ctries"},{"key":"126_CR77","first-page":"OC01","volume":"14","author":"A Bahara","year":"2020","unstructured":"Bahara A. Anti-inflammatory markers IL-10 and IL-35 role in developing gestational diabetes mellitus. J Clin Diagn Res. 2020;14:OC01\u20133.","journal-title":"J Clin Diagn Res"},{"key":"126_CR78","unstructured":"Zhao X, et al. Correlation between inflammatory markers ( hs-CRP , TNF0\u00b1 , IL-1#2 , IL-6 , IL-18 ) , glucose intolerance, and gestational diabetes mellitus in pregnant women. 2018."},{"key":"126_CR79","doi-asserted-by":"publisher","first-page":"1342643","DOI":"10.1155\/2016\/1342643","volume":"2016","author":"E Poniedzialek-Czajkowska","year":"2016","unstructured":"Poniedzialek-Czajkowska E, et al. Intercellular adhesion molecule and endogenous NOS inhibitor: asymmetric dimethylarginine in pregnant women with gestational diabetes mellitus. J Diabetes Res. 2016;2016:1342643.","journal-title":"J Diabetes Res"},{"issue":"1","key":"126_CR80","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/s12020-010-9361-1","volume":"38","author":"M Akturk","year":"2010","unstructured":"Akturk M, et al. Asymmetric dimethylarginine concentrations are elevated in women with gestational diabetes. Endocrine. 2010;38(1):134\u201341.","journal-title":"Endocrine"},{"issue":"3","key":"126_CR81","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1515\/cclm-2015-0537","volume":"54","author":"S Theriault","year":"2016","unstructured":"Theriault S, et al. Early prediction of gestational diabetes: a practical model combining clinical and biochemical markers. Clin Chem Lab Med. 2016;54(3):509\u201318.","journal-title":"Clin Chem Lab Med"},{"key":"126_CR82","doi-asserted-by":"publisher","first-page":"133","DOI":"10.37358\/MP.17.1.4803","volume":"54","author":"W Schaas","year":"2017","unstructured":"Schaas W. Biochemical markers predicting the risk of gestational diabetes mellitus. Mat Plast. 2017;54:133\u20136.","journal-title":"Mat Plast"},{"issue":"6","key":"126_CR83","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s00592-016-0867-8","volume":"53","author":"H Ning","year":"2016","unstructured":"Ning H, et al. Plasma fatty acid-binding protein 4 (FABP4) as a novel biomarker to predict gestational diabetes mellitus. Acta Diabetol. 2016;53(6):891\u20138.","journal-title":"Acta Diabetol"},{"issue":"4","key":"126_CR84","doi-asserted-by":"publisher","first-page":"168","DOI":"10.4103\/aam.aam_53_16","volume":"17","author":"A Mohammed","year":"2018","unstructured":"Mohammed A, Aliyu IS, Manu M. Correlation between circulating level of tumor necrosis factor-alpha and insulin resistance in Nigerian women with gestational diabetes mellitus. Ann Afr Med. 2018;17(4):168\u201371.","journal-title":"Ann Afr Med"},{"key":"126_CR85","unstructured":"Zhou X, et al. Correlation of TNF-a, TNFR1 and adiponectin levels with HOMA-IR in patients with gestational diabetes mellitus. Biomed Res.\u00a02017;28:9549\u201353."},{"key":"126_CR86","doi-asserted-by":"publisher","first-page":"250","DOI":"10.11604\/pamj.2018.31.250.16989","volume":"31","author":"A Mohammed","year":"2018","unstructured":"Mohammed A, Aliyu IS. Maternal serum level of TNF-alpha in Nigerian women with gestational diabetes mellitus. Pan Afr Med J. 2018;31:250.","journal-title":"Pan Afr Med J"},{"issue":"1","key":"126_CR87","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1089\/biores.2018.0013","volume":"7","author":"DC Eschler","year":"2018","unstructured":"Eschler DC, et al. Circulating levels of bone and inflammatory markers in gestational diabetes mellitus. Biores Open Access. 2018;7(1):123\u201330.","journal-title":"Biores Open Access"},{"issue":"1","key":"126_CR88","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00404-015-3615-3","volume":"292","author":"SH Ipekci","year":"2015","unstructured":"Ipekci SH, et al. Serum levels of neopterin in gestational diabetes mellitus: the relationship with Apgar scores. Arch Gynecol Obstet. 2015;292(1):103\u20139.","journal-title":"Arch Gynecol Obstet"},{"issue":"19","key":"126_CR89","doi-asserted-by":"publisher","first-page":"3349","DOI":"10.1080\/14767058.2020.1760833","volume":"33","author":"N Sahin Uysal","year":"2020","unstructured":"Sahin Uysal N, et al. Is the serum delta neutrophil index level different in gestational diabetic women? J Matern Fetal Neonatal Med. 2020;33(19):3349\u201354.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"10","key":"126_CR90","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1080\/09513590.2019.1599856","volume":"35","author":"N Koroglu","year":"2019","unstructured":"Koroglu N, et al. Increased pancreatic-derived factor (PANDER) levels in gestational diabetes mellitus. Gynecol Endocrinol. 2019;35(10):866\u20138.","journal-title":"Gynecol Endocrinol"},{"issue":"4","key":"126_CR91","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1080\/1354750X.2018.1432690","volume":"23","author":"S Adam","year":"2018","unstructured":"Adam S, et al. Association between gestational diabetes and biomarkers: a role in diagnosis. Biomarkers. 2018;23(4):386\u201391.","journal-title":"Biomarkers"},{"issue":"9","key":"126_CR92","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1080\/09513590.2016.1180679","volume":"32","author":"FK Kucukler","year":"2016","unstructured":"Kucukler FK, et al. Low level of nesfatin-1 is associated with gestational diabetes mellitus. Gynecol Endocrinol. 2016;32(9):759\u201361.","journal-title":"Gynecol Endocrinol"},{"issue":"15","key":"126_CR93","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.clinbiochem.2012.05.025","volume":"45","author":"PC Tan","year":"2012","unstructured":"Tan PC, et al. Gamma-glutamyltransferase, alanine transaminase and aspartate transaminase levels and the diagnosis of gestational diabetes mellitus. Clin Biochem. 2012;45(15):1192\u20136.","journal-title":"Clin Biochem"},{"issue":"1","key":"126_CR94","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s12020-015-0567-0","volume":"50","author":"KP Pendeloski","year":"2015","unstructured":"Pendeloski KP, et al. Immunoregulatory molecules in patients with gestational diabetes mellitus. Endocrine. 2015;50(1):99\u2013109.","journal-title":"Endocrine"},{"issue":"2","key":"126_CR95","doi-asserted-by":"publisher","first-page":"e0147277","DOI":"10.1371\/journal.pone.0147277","volume":"11","author":"W Zhao","year":"2016","unstructured":"Zhao W, et al. Relationship between high serum cystatin C levels and the risk of gestational diabetes mellitus. PLoS One. 2016;11(2):e0147277.","journal-title":"PLoS One"},{"issue":"7","key":"126_CR96","doi-asserted-by":"publisher","first-page":"e40947","DOI":"10.1371\/journal.pone.0040947","volume":"7","author":"Y Winhofer","year":"2012","unstructured":"Winhofer Y, et al. CTX (crosslaps) rather than osteopontin is associated with disturbed glucose metabolism in gestational diabetes. PLoS One. 2012;7(7):e40947.","journal-title":"PLoS One"},{"issue":"5","key":"126_CR97","doi-asserted-by":"publisher","first-page":"395","DOI":"10.5603\/GP.2016.0013","volume":"87","author":"UM Ural","year":"2016","unstructured":"Ural UM, et al. Alteration of maternal serum irisin levels in gestational diabetes mellitus. Ginekol Pol. 2016;87(5):395\u20138.","journal-title":"Ginekol Pol"},{"issue":"10","key":"126_CR98","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1507\/endocrj.EJ15-0230","volume":"62","author":"L Zhao","year":"2015","unstructured":"Zhao L, et al. Circulating irisin is lower in gestational diabetes mellitus. Endocr J. 2015;62(10):921\u20136.","journal-title":"Endocr J"},{"issue":"1","key":"126_CR99","first-page":"56","volume":"91","author":"MJ Al-Ghazali","year":"2020","unstructured":"Al-Ghazali MJ, Ali HA, Al-Rufaie MM. Serum irisin levels as a potential marker for diagnosis of gestational diabetes mellitus. Acta Biomed. 2020;91(1):56\u201363.","journal-title":"Acta Biomed"},{"issue":"10","key":"126_CR100","first-page":"749","volume":"83","author":"B Abdullah","year":"2012","unstructured":"Abdullah B, et al. Serum angiopoietin-related growth factor (AGF) levels are elevated in gestational diabetes mellitus and associated with insulin resistance. Ginekol Pol. 2012;83(10):749\u201353.","journal-title":"Ginekol Pol"},{"key":"126_CR101","unstructured":"Mou Y et al. Correlation of serum PEDF concentration with blood lipid in pregnant women with gestational diabetes mellitus. 2016."},{"issue":"3","key":"126_CR102","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1007\/s13410-015-0288-1","volume":"35","author":"H Bekdemir","year":"2015","unstructured":"Bekdemir H, et al. Hemostatic changes in gestational diabetes mellitus. Int J Diabetes Dev Ctries. 2015;35(3):502\u20136.","journal-title":"Int J Diabetes Dev Ctries"},{"issue":"8","key":"126_CR103","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1080\/1354750X.2019.1684562","volume":"24","author":"B Dincgez Cakmak","year":"2019","unstructured":"Dincgez Cakmak B, et al. Assessment of relationship between serum vascular adhesion protein-1 (VAP-1) and gestational diabetes mellitus. Biomarkers. 2019;24(8):750\u20136.","journal-title":"Biomarkers"},{"issue":"24","key":"126_CR104","doi-asserted-by":"publisher","first-page":"4159","DOI":"10.1080\/14767058.2019.1598361","volume":"33","author":"U Gorkem","year":"2020","unstructured":"Gorkem U, Togrul C, Arslan E. Relationship between elevated serum level of placental growth factor and status of gestational diabetes mellitus. J Matern Fetal Neonatal Med. 2020;33(24):4159\u201363.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"4","key":"126_CR105","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1111\/jog.13914","volume":"45","author":"R Melekoglu","year":"2019","unstructured":"Melekoglu R, et al. Evaluation of second trimester amniotic fluid ADAMTS4, ADAMTS5, interleukin-6 and tumor necrosis factor-alpha levels in patients with gestational diabetes mellitus. J Obstet Gynaecol Res. 2019;45(4):824\u20139.","journal-title":"J Obstet Gynaecol Res"},{"issue":"2","key":"126_CR106","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1159\/000475988","volume":"43","author":"F D'Ambrosi","year":"2018","unstructured":"D\u2019Ambrosi F, et al. Maternal subcutaneous and visceral adipose ultrasound thickness in women with gestational diabetes mellitus at 24\u201328 weeks\u2019 gestation. Fetal Diagn Ther. 2018;43(2):143\u20137.","journal-title":"Fetal Diagn Ther"},{"issue":"9","key":"126_CR107","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1055\/s-0042-111435","volume":"48","author":"A Yavuz","year":"2016","unstructured":"Yavuz A, et al. Second trimester fetal and maternal epicardial fat thickness in gestational diabetic pregnancies. Horm Metab Res. 2016;48(9):595\u2013600.","journal-title":"Horm Metab Res"},{"issue":"1","key":"126_CR108","first-page":"13","volume":"10","author":"H Kansu-Celik","year":"2018","unstructured":"Kansu-Celik H, et al. Relationship maternal subcutaneous adipose tissue thickness and development of gestational diabetes mellitus. Interv Med Appl Sci. 2018;10(1):13\u20138.","journal-title":"Interv Med Appl Sci"},{"issue":"2","key":"126_CR109","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s11845-014-1155-7","volume":"184","author":"A Tosun","year":"2015","unstructured":"Tosun A, et al. Utility of superior mesenteric artery Doppler and maternal pancreatic size for predicting gestational diabetes mellitus. Ir J Med Sci. 2015;184(2):499\u2013503.","journal-title":"Ir J Med Sci"},{"issue":"4","key":"126_CR110","doi-asserted-by":"publisher","first-page":"574.e1","DOI":"10.1016\/j.ajog.2020.04.019","volume":"223","author":"J Aguilera","year":"2020","unstructured":"Aguilera J, et al. Paired maternal and fetal cardiac functional measurements in women with gestational diabetes mellitus at 35\u201336 weeks\u2019 gestation. Am J Obstet Gynecol. 2020;223(4):574.e1-574.e15.","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"126_CR111","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1080\/01443615.2018.1434136","volume":"38","author":"G Ilhan","year":"2018","unstructured":"Ilhan G, et al. Preliminary evaluation of foetal liver volume by three-dimensional ultrasound in women with gestational diabetes mellitus. J Obstet Gynaecol. 2018;38(7):922\u20136.","journal-title":"J Obstet Gynaecol"},{"issue":"3","key":"126_CR112","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s00125-016-4166-2","volume":"60","author":"H Venkataraman","year":"2017","unstructured":"Venkataraman H, et al. Increased fetal adiposity prior to diagnosis of gestational diabetes in South Asians: more evidence for the \u2018thin-fat\u2019 baby. Diabetologia. 2017;60(3):399\u2013405.","journal-title":"Diabetologia"},{"issue":"12","key":"126_CR113","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.3109\/14767058.2015.1072164","volume":"29","author":"H Aksoy","year":"2016","unstructured":"Aksoy H, et al. Fetal anterior abdominal wall thickness may be an early ultrasonographic sign of gestational diabetes mellitus. J Matern Fetal Neonatal Med. 2016;29(12):2028\u201332.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"12","key":"126_CR114","doi-asserted-by":"publisher","first-page":"3645","DOI":"10.3390\/nu12123645","volume":"12","author":"D Jin","year":"2020","unstructured":"Jin D, et al. Gestational diabetes mellitus: predictive value of fetal growth measurements by ultrasonography at 22\u201324 weeks: a retrospective cohort study of medical records. Nutrients. 2020;12(12):3645.","journal-title":"Nutrients"},{"issue":"4","key":"126_CR115","doi-asserted-by":"crossref","first-page":"239","DOI":"10.4103\/JMU.JMU_29_20","volume":"28","author":"S Aydin","year":"2020","unstructured":"Aydin S, Fatihoglu E. Fetal epicardial fat thickness: can it serve as a sonographic screening marker for gestational diabetes mellitus? J Med Ultrasound. 2020;28(4):239\u201344.","journal-title":"J Med Ultrasound"},{"issue":"12","key":"126_CR116","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.3109\/14767050903042546","volume":"22","author":"WW To","year":"2009","unstructured":"To WW, Mok CK. Fetal umbilical arterial and venous Doppler measurements in gestational diabetic and nondiabetic pregnancies near term. J Matern Fetal Neonatal Med. 2009;22(12):1176\u201382.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"8","key":"126_CR117","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.3109\/14767058.2011.634458","volume":"25","author":"M Perovic","year":"2012","unstructured":"Perovic M, et al. Sensitivity and specificity of ultrasonography as a screening tool for gestational diabetes mellitus. J Matern Fetal Neonatal Med. 2012;25(8):1348\u201353.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"21","key":"126_CR118","doi-asserted-by":"publisher","first-page":"e6962","DOI":"10.1097\/MD.0000000000006962","volume":"96","author":"X Qi","year":"2017","unstructured":"Qi X, et al. Decreased cord blood estradiol levels in related to mothers with gestational diabetes. Medicine. 2017;96(21):e6962.","journal-title":"Medicine"},{"key":"126_CR119","first-page":"238","volume":"39","author":"A Usta","year":"2017","unstructured":"Usta A, et al. Expression of cyclophilin A in the placental tissue of pregnant women with gestational diabetes mellitus. Anal Quant Cytopathol Histopathol. 2017;39:238\u201346.","journal-title":"Anal Quant Cytopathol Histopathol"},{"issue":"13","key":"126_CR120","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1111\/j.1471-0528.2009.02341.x","volume":"116","author":"E Taricco","year":"2009","unstructured":"Taricco E, et al. Effects of gestational diabetes on fetal oxygen and glucose levels in vivo. BJOG. 2009;116(13):1729\u201335.","journal-title":"BJOG"},{"issue":"1","key":"126_CR121","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jdiacomp.2007.04.002","volume":"23","author":"M Kucuk","year":"2009","unstructured":"Kucuk M, Doymaz F. Placental weight and placental weight-to-birth weight ratio are increased in diet- and exercise-treated gestational diabetes mellitus subjects but not in subjects with one abnormal value on 100-g oral glucose tolerance test. J Diabetes Complications. 2009;23(1):25\u201331.","journal-title":"J Diabetes Complications"},{"issue":"6","key":"126_CR122","first-page":"407","volume":"18","author":"P Pooransari","year":"2020","unstructured":"Pooransari P, et al. Is gross morphology of placenta, umbilical cord, and neonatal outcome in well-controlled gestational diabetes mellitus pregnancy different? A case-control study. Int J Reprod Biomed. 2020;18(6):407\u201314.","journal-title":"Int J Reprod Biomed"},{"issue":"10","key":"126_CR123","first-page":"e11130","volume":"12","author":"AS Dairi","year":"2020","unstructured":"Dairi AS, et al. The effect of gestational diabetes mellitus on the chorionic villi of human placenta among Saudi Arabian mothers: a quantitative and comparative study. Cureus. 2020;12(10):e11130.","journal-title":"Cureus"},{"key":"126_CR124","doi-asserted-by":"crossref","unstructured":"Kadivar M, et al. Histomorphological changes of the placenta and umbilical cord in pregnancies complicated by gestational diabetes mellitus. Placenta. 2020;97:71-78.","DOI":"10.1016\/j.placenta.2020.06.018"},{"issue":"4","key":"126_CR125","doi-asserted-by":"publisher","first-page":"e13020","DOI":"10.1111\/aji.13020","volume":"80","author":"TL Barke","year":"2018","unstructured":"Barke TL, et al. Gestational diabetes mellitus is associated with increased CD163 expression and iron storage in the placenta. Am J Reprod Immunol. 2018;80(4):e13020.","journal-title":"Am J Reprod Immunol"},{"issue":"1","key":"126_CR126","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s00592-008-0060-9","volume":"46","author":"C Anjalakshi","year":"2009","unstructured":"Anjalakshi C, et al. A single test procedure to diagnose gestational diabetes mellitus. Acta Diabetol. 2009;46(1):51\u20134.","journal-title":"Acta Diabetol"},{"key":"126_CR127","doi-asserted-by":"crossref","unstructured":"Tekin YB, Erin KB, Yilmaz A. Evaluation of SCUBE-1 levels as a placental dysfunction marker at gestational diabetes mellitus. Gynecol Endocrinol. 2020;36(5):417\u201320.","DOI":"10.1080\/09513590.2019.1683537"},{"key":"126_CR128","doi-asserted-by":"crossref","unstructured":"S\u00e1nchez-Garc\u00eda A, Rodr\u00edguez-Guti\u00e9rrez R, Sald\u00edvar-Rodr\u00edguez D, Guzm\u00e1n-L\u00f3pez A, Castillo-Castro C, Mancillas-Adame L, Santos-Santillana K, Gonz\u00e1lez-Nava V, Gonz\u00e1lez-Gonz\u00e1lez JG. Diagnostic accuracy of the triglyceride-glucose index for gestational diabetes screening: a practical approach. Gynecol Endocrinol. 2020;36(12):1112\u20135.","DOI":"10.1080\/09513590.2020.1742687"},{"key":"126_CR129","doi-asserted-by":"crossref","unstructured":"Gingras V, Rifas-Shiman S, Switkowski K, Oken E, Hivert MF. Mid-Pregnancy Fructosamine Measurement\u2014Predictive Value for Gestational Diabetes and Association with Postpartum Glycemic Indices. Nutrients. 2018;10(12):2003.","DOI":"10.3390\/nu10122003"},{"issue":"1","key":"126_CR130","first-page":"710","volume":"19","author":"X Wang","year":"2020","unstructured":"Wang X, et al. Expression and correlation of Chemerin and FABP4 in peripheral blood of gestational diabetes mellitus patients. Exp Ther Med. 2020;19(1):710\u20136.","journal-title":"Exp Ther Med"},{"key":"126_CR131","doi-asserted-by":"crossref","unstructured":"Yilmaz H, Celik H, Namuslu M, Inan O, Onaran Y, Karakurt F, Ayyildiz A, Bilgic M, Bavbek N, Akcay A. Benefits of the Neutrophil-to-Lymphocyte Ratio for the Prediction of Gestational Diabetes Mellitus in Pregnant Women. Exp Clin Endocrinol Diabetes.\u00a02014;122(01):39\u201343.","DOI":"10.1055\/s-0033-1361087"},{"key":"126_CR132","doi-asserted-by":"crossref","unstructured":"Butt A, Malik U, Waheed K, Khanum A, Firdous S, Ejaz S, Randhawa F, Shakoori T. Low Serum Cobalamin is a Risk Factor for Gestational Diabetes. Pakistan J Zool. 2017;49(6).","DOI":"10.17582\/journal.pjz\/2017.49.6.1963.1968"},{"key":"126_CR133","doi-asserted-by":"crossref","unstructured":"Giacobbe A, Granese R, Grasso R, Salpietro V, Corrado F, Giorgianni G, Foti G, Amadore D, Triolo O, Giunta L, Di Benedetto A. Association between maternal serum high mobility group box 1 levels and pregnancy complicated by gestational diabetes mellitus. Nutr Metab Cardiovasc Di. 2016;26 (5):414\u20138.","DOI":"10.1016\/j.numecd.2016.02.007"},{"key":"126_CR134","doi-asserted-by":"crossref","unstructured":"Renz, P.B., et al., Diagnostic accuracy of glycated hemoglobin for gestational diabetes mellitus: a systematic review and meta-analysis. Clin Chem Lab Med. 2019;57(10):1435\u201349.","DOI":"10.1515\/cclm-2018-1191"},{"key":"126_CR135","doi-asserted-by":"crossref","unstructured":"Wang X, et al. Expression and correlation of Chemerin and FABP4 inperipheral blood of gestational diabetes mellitus patients. Exp Ther Med.2020;19(1):710\u20136.","DOI":"10.3892\/etm.2019.8247"},{"key":"126_CR136","doi-asserted-by":"crossref","unstructured":"Kosack CS, Page AL, Klatser PR. A guide to aid the selection of diagnostic tests. Bull World Health Organ. 2017;95(9):639-45. 10.2471\/BLT.16.187468. Epub 2017 Jun 26. PMID: 28867844; PMCID: PMC5578377.","DOI":"10.2471\/BLT.16.187468"},{"key":"126_CR137","doi-asserted-by":"crossref","unstructured":"Retnakaran R, et al. Serum apoA1 (Apolipoprotein A-1), insulin resistance, and the risk of gestational diabetes mellitus in human pregnancy-brief report. Arterioscler Thromb Vasc Biol. 2019;39(10):2192\u20137.","DOI":"10.1161\/ATVBAHA.119.313195"},{"issue":"5","key":"126_CR138","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1515\/jpm-2019-0457","volume":"48","author":"P Jatavan","year":"2020","unstructured":"Jatavan P, et al. The correlation of fetal cardiac function with gestational diabetes mellitus (GDM) and oxidative stress levels. J Perinat Med. 2020;48(5):471\u20136.","journal-title":"J Perinat Med"},{"issue":"11","key":"126_CR139","doi-asserted-by":"publisher","first-page":"3451","DOI":"10.3390\/jcm9113451","volume":"9","author":"D Bogdanet","year":"2020","unstructured":"Bogdanet D, et al. The oral glucose tolerance test-is it time for a change?-a literature review with an emphasis on pregnancy. J Clin Med. 2020;9(11):3451.","journal-title":"J Clin Med"},{"issue":"1","key":"126_CR140","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1186\/s13104-017-2944-7","volume":"10","author":"YN Munang","year":"2017","unstructured":"Munang YN, et al. Reproducibility of the 75 g oral glucose tolerance test for the diagnosis of gestational diabetes mellitus in a sub-Saharan African population. BMC Res Notes. 2017;10(1):622.","journal-title":"BMC Res Notes"},{"key":"126_CR141","unstructured":"Flick. Triangulation (Handbuch Qualitative Sozialforschung). 1995, Weinheim, Germany. 12."},{"key":"126_CR142","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1080\/1612197X.2003.9671705","volume":"1","author":"D Hackfort","year":"2003","unstructured":"Hackfort D. Triangulation as a basis for diagnostic judgments. Int J Sport Exerc Psychol. 2003;1:82\u201394.","journal-title":"Int J Sport Exerc Psychol"},{"issue":"10","key":"126_CR143","doi-asserted-by":"publisher","first-page":"e0223832","DOI":"10.1371\/journal.pone.0223832","volume":"14","author":"CM UmemnekuChikere","year":"2019","unstructured":"UmemnekuChikere CM, et al. Diagnostic test evaluation methodology: a systematic review of methods employed to evaluate diagnostic tests in the absence of gold standard - an update. PLoS One. 2019;14(10):e0223832.","journal-title":"PLoS One"}],"container-title":["Clinical Diabetes and Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40842-021-00126-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40842-021-00126-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40842-021-00126-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T15:32:56Z","timestamp":1725895976000},"score":1,"resource":{"primary":{"URL":"https:\/\/clindiabetesendo.biomedcentral.com\/articles\/10.1186\/s40842-021-00126-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,11]]},"references-count":143,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["126"],"URL":"https:\/\/doi.org\/10.1186\/s40842-021-00126-7","relation":{},"ISSN":["2055-8260"],"issn-type":[{"value":"2055-8260","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,11]]},"assertion":[{"value":"28 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19"}}